10/12/2021 | BioRegio STERN Management GmbH | Press

“smart analytics” – quality assurance for mRNA vaccines

(Stuttgart/Reutlingen) – The Zentrales Innovationsprogramm Mittelstand (ZIM, the Central Innovation Programme for small and medium-sized enterprises), which is run by the  German Federal Ministry for Economic Affairs and Energy (BMWi), has been helping to establish the international “smart analytics” network since May 2020. This network is  geared toward developing innovative analytical methods and applications for use in healthcare, industry and the research sector. Funding has now been announced for the first  research and development project, which will see Reutlingen-based 4base lab AG develop new approaches for the testing and quality control of mRNA-based vaccines.

Förderhinweis ZIM Smart Analytics

Interested companies can apply now to Dr. Verena Grimm:
grimm@bioregio-stern.de, tel.: +49 (0)711-870354-27

About 4base lab AG:
4base lab AG is a biotech company based in Technologiepark Reutlingen that has been involved in developing and manufacturing mRNA vaccines against carcinogens
and infectious agents since 2005. The company is accredited or certified to various regulatory standards such as GMP standards, DIN EN ISO 9001:2015, DIN EN ISO
14001:2015 and DIN EN ISO/IEC 17025:2018. It offers extensive expertise in analytical requirements for testing the quality and identity of these molecules and validating them across the entire development and production process for this innovative class of medicinal products.

About BioRegio STERN Management GmbH:
BioRegio STERN Management GmbH promotes economic development in the life sciences industry, helping to strengthen the region as a business location by supporting
innovations and start-up companies in the public interest. It is the main point of contact for company founders and entrepreneurs in the Stuttgart and Neckar-Alb regions,
including the cities of Tübingen and Reutlingen. The STERN BioRegion is one of the largest and most successful bioregions in Germany. Its unique selling points include a mix of biotech and medtech companies that is outstanding in Germany and regional clusters in the fields of automation technology and mechanical engineering.

Source:
BioRegio STERN Management GmbH